Tarsus Pharmaceuticals, Inc.
TARS
$68.90
$0.941.38%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 417.27M | 401.84M | 381.14M | 407.92M | 291.38M |
| Total Receivables | 87.11M | 74.34M | 60.24M | 64.15M | 48.06M |
| Inventory | 4.37M | 3.84M | 3.87M | 2.71M | 2.62M |
| Prepaid Expenses | 13.47M | 21.70M | 29.17M | 6.00M | 14.65M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 560.00K | -- | -- | -- | -- |
| Total Current Assets | 522.78M | 501.70M | 474.43M | 480.77M | 356.71M |
|
|
|||||
| Total Current Assets | 522.78M | 501.70M | 474.43M | 480.77M | 356.71M |
| Net Property, Plant & Equipment | 21.75M | 15.98M | 3.41M | 3.18M | 2.87M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 7.37M | 7.61M | 7.85M | 8.09M | 8.33M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.40M | 6.27M | 6.31M | 5.71M | 6.09M |
| Total Assets | 562.16M | 534.56M | 494.99M | 500.75M | 376.99M |
|
|
|||||
| Total Accounts Payable | 16.39M | 40.64M | 28.08M | 28.38M | 9.42M |
| Total Accrued Expenses | 26.88M | 19.98M | 16.74M | 13.85M | 19.14M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 80.00K | 317.00K | 384.00K | 608.00K |
| Total Finance Division Other Current Liabilities | 92.43M | 56.35M | 45.12M | 43.69M | 51.44M |
| Total Other Current Liabilities | 92.43M | 56.35M | 45.12M | 43.69M | 51.44M |
| Total Current Liabilities | 135.70M | 117.05M | 90.25M | 86.31M | 80.61M |
|
|
|||||
| Total Current Liabilities | 135.70M | 117.05M | 90.25M | 86.31M | 80.61M |
| Long-Term Debt | 72.44M | 72.28M | 72.13M | 71.98M | 71.85M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 10.60M | 10.15M | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 218.73M | 199.48M | 162.38M | 158.29M | 152.46M |
|
|
|||||
| Common Stock & APIC | 769.67M | 753.05M | 738.24M | 727.70M | 584.57M |
| Retained Earnings | -426.63M | -418.26M | -405.67M | -385.33M | -360.21M |
| Treasury Stock & Other | 381.00K | 289.00K | 39.00K | 85.00K | 179.00K |
| Total Common Equity | 343.43M | 335.08M | 332.61M | 342.46M | 224.53M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 343.43M | 335.08M | 332.61M | 342.46M | 224.53M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 343.43M | 335.08M | 332.61M | 342.46M | 224.53M |
|
|
|||||